Novartis Takes Huntington's Path With SMA Therapy Branaplam

Priority Has Shifted After Rival Roche's Success

 
• By Kevin Grogan
  
Head icon
Huntington's is a progressive brain disorder caused by a defective gene • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas